August 2024 CASE REPORT: IDH-MUTANT GRADE II OLIGODENDROGLIOMANorthwestern Medicine Neuro-oncologist Karan S. Dixit, MD, presents the case of a 35-year-old patient with IDH mutant 1p/19q oligodendroglioma and explains the rationale behind opting for observation over adjuvant therapy after surgery.
|
Karan Dixit, MD, assistant professor in the Ken and Ruth Davee Department of Neurology’s Divisions of Neuro-oncology and Hospital Neurology.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|